Pfizer Strikes Up To $10.5 Billion Deal With Innovent Biologics - Pfizer (NYSE:PFE)

Pfizer and Innovent Biologics sign a $10.5 billion cancer drug deal to develop 12 oncology programs globally.

Raccontata damorningstar.combiopharmadive.comthehindubusinessline.comasia.nikkei.comcnbc.comscmp.combenzinga.compharmaceutical-technology.comstartmag.itendpoints.newsqz.com